Streetbeat News

Earnings

CODX

Co-Diagnostics (NASDAQ:CODX) reported Q3 2023 GAAP EPS of $(0.20), beating the analyst consensus estimate of $(0.29) by 31.03%. The company also reported quarterly sales of $2.46M, surpassing the analyst consensus estimate of $200.00K by 1.13K%. However, these figures represent a decrease from the same period last year.

Portfolio Pulse from saritha@benzinga.com

November 09, 2023 | 9:59 pm

LNW

Light & Wonder reported Q3 revenue of $731M, surpassing the estimated $717.31M.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 9:58 pm

BRNS

Barinthus Biotherapeutics reported a Q3 EPS of $(0.37), a decrease from $0.22 YoY.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 9:58 pm

EVBG

Everbridge has projected its Q4 adjusted EPS to be between $0.48 and $0.52, compared to the estimated $0.51. The company also expects its revenue to be between $114M and $115.5M, lower than the estimated $118.26M.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 9:58 pm

SYNA

Synaptics reported better-than-expected Q1 financial results, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 9:57 pm

RSSS

Research Solutions (NASDAQ:RSSS) reported Q1 2023 GAAP EPS of $(0.04), missing the estimate of $(0.03) by 33.33%. This is a 500% decrease from the same period last year. However, the company's quarterly sales of $10.06M beat the estimate of $9.88M by 1.83%, marking a 15.84% increase from the same period last year.

Portfolio Pulse from saritha@benzinga.com

November 09, 2023 | 9:57 pm

TGAN

Transphorm (NASDAQ:TGAN) reported Q2 adjusted EPS of $(0.08), beating the estimate of $(0.10) by 20%. However, the company's sales of $5.01M missed the estimate of $5.30M by 5.47%. The EPS is an 11.11% increase from last year, while sales increased by 36.51% from the same period last year.

Portfolio Pulse from bharat@benzinga.com

November 09, 2023 | 9:57 pm

WRAP

Wrap Technologies (NASDAQ:WRAP) reported Q3 losses of $(0.07) per share, a 22.22% improvement from $(0.09) per share YoY. The company's sales also increased by 113.46% to $3.63 million from $1.70 million YoY.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 9:57 pm

CTLP

Cantaloupe reported its Q1 revenue of $62.7M, which is slightly lower than the estimated $64.098M. The company's EPS stands at $0.02.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 9:57 pm

AXDX

Accelerate Diagnostics (NASDAQ:AXDX) reported its Q3 earnings, missing estimated earnings by 10.28% with an EPS of $-1.18 versus an estimate of $-1.07. However, revenue was up $339 thousand from the same period last year. Last quarter, the company beat EPS estimates, which was followed by a 2.92% increase in the share price.

Portfolio Pulse from Benzinga Insights

November 09, 2023 | 9:57 pm